WORK Medical Technology Group LTD financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Public ticker
WOK on Nasdaq
Latest financial report
30 Jan 2026
Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Auckland City
SEC filing record 1 source field available
Fiscal year end
30 September

Shareable Research Card

WOK - WORK Medical Technology Group LTD Financial Facts

WOK - WORK Medical Technology Group LTD has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q3 2025

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q3 2025
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q3 2025.
  • Most recent SEC facts end date on this page: 30 Sep 2025.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for WOK - WORK Medical Technology Group LTD

New fact period available

Latest financial period: Q3 2025. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

30 Jan 2026

Page type

Company facts

Latest period

Q3 2025

SEC-backed company facts were refreshed from filings filed on 30 Jan 2026.

Open recent updates hub Open latest 10-Q/10-K hub

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Key facts

  • WOK - WORK Medical Technology Group LTD financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric summary will appear when SEC facts are available.

Change

  • No metrics are currently available for comparison on this facts page.
  • Changes will populate automatically as new 10-Q/10-K periods are processed.

Research use

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

View source filing

Valuation Snapshot

SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.

DCF value materially above price Undervalued Medium confidence

33%

fair value gap

Fair value per share

$2.61

Market price

$1.96

WOK - Local security

PEG ratio

n/a

Enterprise value

$71.53M

Equity value

$75.62M

DCF fair value scenarios

Bear

$1.98

About fair
Growth
1%
Discount
11%
Terminal
2%

Gap 1.2%

Base

$2.61

Undervalued
Growth
4%
Discount
10%
Terminal
2.5%

Gap 33%

Bull

$3.59

Undervalued
Growth
7%
Discount
9%
Terminal
3%

Gap 83%

Base growth: DCF Growth Assumption.

Key valuation metrics

EV/Revenue

n/a

Local security market EV / SEC revenue

Revenue is unavailable or not positive

EV/EBITDA

n/a

Local security market EV / SEC EBITDA

Ebitda is unavailable or not positive

P/E

n/a

Local security market price / SEC EPS

Net income is unavailable or not positive

P/S

n/a

Local security market cap / SEC revenue

Revenue is unavailable or not positive

P/B

3.1x

Local security market cap / SEC equity

PEG

n/a

P/E / DCF Growth Assumption

P/e or positive growth is unavailable

Core assumptions

Projection
5 years
FCF growth
4%
Discount rate
10%
Terminal growth
2.5%

SEC fact inputs

DCF base FCF
$4.91M
Trailing SEC FCF
Reported FCF
$4.91M
Net income
$1.07M
EBITDA
n/a
Cash
$4.09M
Debt
n/a
Equity
$18.34M
Shares
28,983,269

Data confidence notes

  • Dcf base free cash flow: dcf base starts from trailing sec free cash flow
  • Debt missing: equity value treats debt as 0
  • Peg unavailable: earnings per share is not positive

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

n/a

Insufficient Data Confidence low

Financial Health

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $1,724,551 +15%
Accounts Receivable, after Allowance for Credit Loss, Current $615,838 -63%
Accumulated Other Comprehensive Income (Loss), Net of Tax $608,729 -49%
Assets $33,156,256 -8.5%
Assets, Current $20,455,133 -1.8%
Cash and Cash Equivalents, at Carrying Value $4,088,599 -38%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,088,599 -38%
Contract with Customer, Liability, Current $402,407 -36%
Deferred Income Tax Liabilities, Net $1,303
Deferred Tax Assets, Gross $1,160,949 +253%
Deferred Tax Assets, Operating Loss Carryforwards $1,094,845 +1300%
Deferred Tax Assets, Valuation Allowance $1,160,949 +1384%
Employee-related Liabilities, Current $513,578 +122%
Intangible Assets, Net (Excluding Goodwill) $959,116 -8.1%
Inventory, Net $2,455,477 -23%
Liabilities $11,991,525 -41%
Liabilities and Equity $33,156,256 -8.5%
Liabilities, Current $11,971,466 -41%
Operating Lease, Liability, Current $6,743
Operating Lease, Liability, Noncurrent $18,756
Operating Lease, Right-of-Use Asset $26,060
Property, Plant and Equipment, Gross $17,425,813 -1.2%
Property, Plant and Equipment, Net $10,587,852 -6.9%
Retained Earnings (Accumulated Deficit) $4,958,991 -18%
Stockholders' Equity Attributable to Parent $18,338,941 +39%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $21,164,731 +32%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .